Article

Fourier-based wavefront LASEK appears promising

Wavefront assessments showed mean HOAs had decreased significantlyby 44% from baseline, and there were mean decreases of 38% intrefoil.

New Orleans-Preliminary results from small studies suggest Fourier-based wavefront LASEK may provide a safe and effective method for enhancing highly aberrated eyes that have had previous radial keratotomy (RK) or LASIK, said Marguerite B. McDonald, MD, FACS.

For the post-RK eyes, mean uncorrected visual acuity (UCVA) improved from 20/50 preoperatively to 20/16 at 3 months. Mean UCVA for the post-LASIK cohort had improved from 20/100 to 20/25. In both groups, mean total higher-order aberrations (HOAs) had decreased significantly, and there were no complications or adverse events, reported Dr. McDonald, clinical professor of ophthalmology, Tulane University, and Director, Southern Vision Institute, New Orleans.

"The results achieved so far with these Fourier-based LASEK treatments are promising. However, these are small series with short follow-up, and we still need accurate, topographically guided ablation programs for eyes that are too highly aberrated to capture and analyze data with Hartmann-Shack systems," Dr. McDonald said.

The post-LASIK eyes were ablated on top of their flaps without lifting them; no alcohol was used but an attempt was made to save the small strips of epithelium that had been lifted, so that the procedures were really hybrids of PRK and LASEK. The ablations were done using a 6-mm optical zone and 8-mm blend zone. All of the treatments so far have been done without physician or percent nomogram adjustments.

Dr. McDonald observed that re-epithelialization in the post-RK eyes was slower compared with LASEK in virgin eyes. Mean UCVA was 20/50 on days 1 and 4 postoperatively and improved to 20/32 on day 6.

"It took 6 days before the average patient could drive without correction, which is a slower rate of recovery than that found in virgin eyes," she said.

Five eyes in that group were seen at 1 month, and UCVA at that visit ranged from 20/16 to 20/20. At the 3-month visit, mean best-corrected visual acuity (BCVA) had improved from 20/25 preoperatively to 20/20.

Mean manifest refractive spherical equivalent (MRSE) was +1.89 D preoperatively with a range up to +4.12 D. At 1 month, the eyes seen were slightly myopic (–0.31 D). Mean MRSE at 3 months was still slightly myopic (–0.42 D) with a tight range between –0.5 and –0.25 D. Manifest cylinder ranged from +0.5 to +2.25 D preoperatively with a mean of +1.16 D. At 3 months, manifest cylinder was 0.0 D in all eyes.

Wavefront assessments showed mean higher-order aberrations (HOAs) had decreased significantly by 44% from baseline, and there were mean decreases of 38% in trefoil and 100% in spherical aberration.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.